American Heart Association. (1988). Dietary treatment of hypercholesterolemia: A manual for patients. Dallas, TX: author.
2.
FrickM.H.EloO.HaapaK.HeinonenO.P.HeinsalmiP.HeloP.HuttunenJ.K.KaitaniemiP.KoskinenP., & ManninenV. (1987). Helsinski Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med, 317, 1237–1245.
3.
GrundyS.M. (1988a). HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia. N Engl J Med, 319, 24–33.
4.
GrundyS.M. (1988b). New pharmacologic agents: How they work. Modern Medicine, 56, 13–21.
5.
LeesA.M.SteinS.W., & LeesR.S. (1986). Therapy of hypercholesterolemia with mevinolin and other lipid-lowering drugs. Circulation, 74(suppl II), 200.
6.
Lovastatin Study Group II. (1986). Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. JAMA, 256, 2829–2834.
7.
National Cholesterol Education Program. (1987). Highlights of the report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Bethesda, MD: National Institutes of Health. Publication 88–2926.
8.
SchuckerM.A.BaileyK.HeimbachJ.T.MattsonM.E.WittesJ.T.HainesC.M.GordonD.J.CutlerJ.A.KeatingV.S.GoorR.S., & RifkindB.M. (1987). Change in public perspective on cholesterol and heart disease. JAMA, 258, 3527–3531.
9.
Van ItalieT.B., & YangM.-U. (1987). Current concepts in nutrition and weight loss. N Engl J Med, 297, 1158–1161.